Literature DB >> 7019092

Rubella-associated arthritis: rescue of rubella virus from peripheral blood lymphocytes two years postvaccination.

J K Chantler, D K Ford, A J Tingle.   

Abstract

Rubella virus was isolated from the peripheral lymphocytes of a patient with rubella-associated arthritis 2 years after rubella vaccination. The rescue of the virus was carried out by stimulating the lymphocytes with mitogens for several days in cultures and then cocultivating them with RK13 cells at 35 degrees C. Rubella virus was detected by a variety of techniques, including electron microscopy, indirect immunofluorescence, polyacrylamide gel analysis of labeled viral proteins, and microfocus assay for infectious virus particles. Assessment of the immune status of the patient did not indicate any impairment of immune function associated with long-term persistence of the virus.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7019092      PMCID: PMC351589          DOI: 10.1128/iai.32.3.1274-1280.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  A study of microfoci and inclusion bodies produced by rubella virus in the RK-13 cell line.

Authors:  G Kouri; A Aguilera; P Rodriguez; M Korolev
Journal:  J Gen Virol       Date:  1974-01       Impact factor: 3.891

2.  Lymphocyte viraemia in congenital rubella.

Authors:  M J Simons; I Jack
Journal:  Lancet       Date:  1968-11-02       Impact factor: 79.321

3.  Rubella virus and human lymphocytes in culture.

Authors:  M J Simons; M G Fitzgerald
Journal:  Lancet       Date:  1968-11-02       Impact factor: 79.321

4.  Rheumatoid arthritis after rubella.

Authors:  T W Martenis; J H Bland; C A Phillips
Journal:  Arthritis Rheum       Date:  1968-10

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Micromorphological aspects of the development of rubella virus in BHK-21 cells.

Authors:  M R Edwards; S M Cohen; M Bruno; R Deibel
Journal:  J Virol       Date:  1969-04       Impact factor: 5.103

7.  Live rubella vaccines in adults and children. HPV-77 and Merck-Benoit strains.

Authors:  R E Weibel; J Stokes; E B Buynak; M R Hilleman
Journal:  Am J Dis Child       Date:  1969-08

8.  Transient arthritis after rubella vaccination.

Authors:  L Z Cooper; P R Ziring; H J Weiss; B A Matters; S Krugman
Journal:  Am J Dis Child       Date:  1969-08

9.  Arthritis associated with induced rubella infection.

Authors:  P L Ogra; J K Herd
Journal:  J Immunol       Date:  1971-09       Impact factor: 5.422

10.  Rubella synovitis in a one-year-old patient.

Authors:  H M Hildebrandt; H F Maassab
Journal:  N Engl J Med       Date:  1966-06-23       Impact factor: 91.245

View more
  13 in total

Review 1.  Long-term humoral immunity against viruses: revisiting the issue of plasma cell longevity.

Authors:  M K Slifka; R Ahmed
Journal:  Trends Microbiol       Date:  1996-10       Impact factor: 17.079

2.  Mapping of genetic determinants of rubella virus associated with growth in joint tissue.

Authors:  K D Lund; J K Chantler
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Preventing the congenital rubella syndrome by vaccinating women at risk.

Authors:  J H Joncas
Journal:  Can Med Assoc J       Date:  1983-07-15       Impact factor: 8.262

Review 4.  Use of licensed vaccines for active immunization of the immunocompromised host.

Authors:  L A Pirofski; A Casadevall
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

5.  Autoantigens interact with cis-acting elements of rubella virus RNA.

Authors:  G P Pogue; J Hofmann; R Duncan; J M Best; J Etherington; R D Sontheimer; H L Nakhasi
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

6.  Human T- and B-cell epitopes of E1 glycoprotein of rubella virus.

Authors:  H Chaye; D Ou; P Chong; S Gillam
Journal:  J Clin Immunol       Date:  1993-03       Impact factor: 8.317

7.  Rubella virus-specific cytotoxic T-lymphocyte responses: identification of the capsid as a target of major histocompatibility complex class I-restricted lysis and definition of two epitopes.

Authors:  A E Lovett; C S Hahn; C M Rice; T K Frey; J S Wolinsky
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

8.  Rubella-specific immune complexes after congenital infection and vaccination.

Authors:  P K Coyle; J S Wolinsky; E Buimovici-Klein; R Moucha; L Z Cooper
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

9.  Immune responses to wild and vaccine rubella viruses after rubella vaccination.

Authors:  M G Cusi; R Metelli; P E Valensin
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

10.  Prospective immunological assessment of arthritis induced by rubella vaccine.

Authors:  A J Tingle; T Yang; M Allen; G D Kettyls; R P Larke; M Schulzer
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.